← Explore

Meta-Skin-Based Ultrasonic Instrument Enabling Highly Selective Ultrasound Stimulation and Treatment

Zong-Lin Li, Ping Chen, Kun Chen, Hu Cai, Wang Yun, Lai-Xin Huang, Guang Yang, Jinjing Zhang, Yu-Gui Peng, Xue-Feng Zhu

Advanced Devices & Instrumentation 2025 · 10.34133/adi.0099

rodenthealthyparkinsons diseaseemg mepinvasive electrophysiologybehaviour

Abstract

The rapid development of metasurface has produced new possibilities for manipulating the sound waves with unprecedented precision and versatility. Leveraging advanced processing techniques such as 3-dimensional (3D) printing and nano-/micro-etching, various metasurface devices were implemented with remarkable capabilities in achieving the exceptional sound reflection and transmission. In biomedical engineering, successful applications of acoustic metasurface devices remain elusive due to many challenges such as impedance mismatching between instruments and issues, and the requirement of 2D fingerprint for integration and biocompatibility. Here, we propose a prototype of meta-skin-based ultrasonic instrument for applications of highly selective ultrasound neurostimulation and treatment. The meta-skin is flexible and biocompatible, with a thickness of only 20 μm (~ 1 / 15 of ultrasound wavelength at 5 MHz). The meta-skin can be further patterned into a meta-lens, which is sealed in hydrogel with a transducer. The meta-skin-based device can be seamlessly attached to tissues or skulls of animals with acoustic transparency and subwavelength-scale focusing (focal spot size ~220 μm). As an example, we utilized the meta-skin-based instrument to selectively stimulate sciatic nerves in rats. Moreover, the proposed device can make the focused ultrasound beam penetrate the skull and accurately stimulate small nucleus in target regions of the brain, which provides a potential therapeutic treatment for Parkinson’s disease.

Abstract via crossref.

Speciesrat (Sprague-Dawley, male)
Subjects10 animals
Sessions per subjectnot reported
Randomisednot reported
Blindingnot reported
Sham / controlno treatment control
Auditory controlnot reported
Readout timingboth
Anaesthesiaanaesthetised
Readoutsemg mep, invasive electrophysiology, behaviour — compound action potentials of sciatic nerve branches; CMAP of tibialis anterior and gastrocnemius; LFP spectra and PSD in M1; AIM dyskinesia scores
Direction of effectmixed or unclearMeta-lens focusing raised sciatic CAP amplitude (357 to 5,460 uV at 300 cycles) and allowed selective peroneal versus tibial activation. In 6-OHDA PD rats, daily STN ultrasound with L-DOPA reduced AIM scores and abolished the high-gamma LFP peak seen with L-DOPA alone.
Adverse eventsnot reportedUltrasound output was paused for 4 s after every 2 s of stimulation to avoid local temperature rise in the nerve experiment.

Exposures

Exposure 1: Meta-skin lens, peroneal and tibial nerve bundles

Target: sciatic nerve, peroneal nerve, tibial nerve — “sciatic nerves (peroneal and tibial nerve bundles)”
Device: custom-built · meta-skin acoustic meta-lens sealed in hydrogel with a piezo-transducer

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)not reported⚑
Pulse duration (ms)not reported
Pulse repetition frequency (Hz)1,000✓✓✓⚑
Duty cycle (%)not reported
Sonication duration (s)2✓✓✓⚑
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

Periodic electric pulses with a repetition period of 1 ms, each pulse containing 100 to 550 cycles (increased from 100 to 550 in steps of 50; 300 cycles for the lens comparison); ultrasound output paused for 4 s after every 2 s of stimulation. Frequency varied to shift focal depth.

Exposure 2: Meta-skin lens through skull, subthalamic nucleus (PD rats)

Target: subthalamic nucleus — “STN”
Device: custom-built · meta-skin acoustic meta-lens sealed in hydrogel with a piezo-transducer

Pulse timing
Waveformnot reported
Fundamental frequency (kHz)5,000✓✓✓⚑
Pulse duration (ms)not reported
Pulse repetition frequency (Hz)not reported
Duty cycle (%)not reported
Sonication duration (s)1,800✓✓✓⚑
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatemeasurementsingle value
In-situ pressure (kPa)540✓✓✓⚑
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

30 min of daily ultrasound stimulation followed by an L-DOPA injection, for 14 days; pulse timing for the STN experiment is not stated.

Flags from extraction

  • exposures[1].in_situ.pressure_kpa — 0.54 MPa was measured through a skull model immersed in water (Fig. 1D), not in the animals; recorded as in_situ measurement, peak or peak-to-peak not stated.
  • exposures[1].fundamental_frequency_khz — 5 MHz is the frequency at which the focal spot was described; the STN stimulation frequency is not restated and the paper says focal depth is tuned by frequency.
  • exposures[0].fundamental_frequency_khz — Frequency for the sciatic experiments not stated (varied to adjust focal depth).
  • exposures[0].timing.pulse_repetition_frequency_hz — Text says 'the pulse repetition frequency is 1 ms'; read as a 1 ms period, converted to 1000 Hz.
  • exposures[0].timing.sonication_duration_s — 2 s of stimulation then 4 s pause.
  • n_subjects — Only the STN experiment states group size (10 PD rats with ultrasound); sciatic nerve rat number not stated.
  • anaesthesia — Sciatic experiments under pentobarbital; anaesthesia during daily STN stimulation not stated.
  • exposures[1].timing.sonication_duration_s — 30 min daily stimulation session; duty of pulses not given.
  • n_sessions_per_subject — 14 days of daily stimulation described, but the count of sessions per rat is not stated as a number in the stimulation sentence; left not_reported.
  • conditions — Sciatic nerve rats are normal rats; 'healthy' inferred from absence of a disease model.